- Home
- CSV vs KROS Comparison
CSV vs KROS Comparison
Compare CSV & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSV
- KROS
- Stock Information
- Founded
- CSV 1991
- KROS 2015
- Country
- CSV United States
- KROS United States
- Employees
- CSV N/A
- KROS N/A
- Industry
- CSV Other Consumer Services
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- CSV Consumer Discretionary
- KROS Health Care
- Exchange
- CSV Nasdaq
- KROS Nasdaq
- Market Cap
- CSV 616.5M
- KROS 589.8M
- IPO Year
- CSV 1996
- KROS 2020
- Fundamental
- Price
- CSV $39.62
- KROS $11.84
- Analyst Decision
- CSV Strong Buy
- KROS Buy
- Analyst Count
- CSV 2
- KROS 11
- Target Price
- CSV $45.00
- KROS $45.33
- AVG Volume (30 Days)
- CSV 79.8K
- KROS 2.1M
- Earning Date
- CSV 02-19-2025
- KROS 02-26-2025
- Dividend Yield
- CSV 1.14%
- KROS N/A
- EPS Growth
- CSV 15.90
- KROS N/A
- EPS
- CSV 2.23
- KROS N/A
- Revenue
- CSV $405,332,000.00
- KROS $651,000.00
- Revenue This Year
- CSV $6.46
- KROS $303.27
- Revenue Next Year
- CSV $4.11
- KROS N/A
- P/E Ratio
- CSV $17.77
- KROS N/A
- Revenue Growth
- CSV 7.34
- KROS 8037.50
- 52 Week Low
- CSV $22.96
- KROS $9.78
- 52 Week High
- CSV $42.13
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- CSV 50.13
- KROS 24.87
- Support Level
- CSV $39.67
- KROS $10.95
- Resistance Level
- CSV $41.11
- KROS $11.63
- Average True Range (ATR)
- CSV 0.83
- KROS 0.87
- MACD
- CSV -0.03
- KROS 1.31
- Stochastic Oscillator
- CSV 49.32
- KROS 30.60
About CSV Carriage Services Inc.
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum crypts, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.